These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 17317594

  • 1. Cholera vaccines.
    Kabir S.
    Lancet Infect Dis; 2007 Mar; 7(3):176-8; author reply 178. PubMed ID: 17317594
    [No Abstract] [Full Text] [Related]

  • 2. Urgent need of cholera vaccines in public health-control programs.
    Clemens J, Holmgren J.
    Future Microbiol; 2009 May; 4(4):381-5. PubMed ID: 19416006
    [No Abstract] [Full Text] [Related]

  • 3. Cholera vaccines: WHO position paper – August 2017.
    Wkly Epidemiol Rec; 2017 Aug 25; 92(34):477-98. PubMed ID: 28845659
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF, Dietrich G, Favre D.
    Vaccine; 2004 Jun 23; 22(19):2457-69. PubMed ID: 15193410
    [Abstract] [Full Text] [Related]

  • 11. Cholera vaccine inactivated oral.
    Drugs R D; 1999 Sep 23; 2(3):193-4. PubMed ID: 10641223
    [No Abstract] [Full Text] [Related]

  • 12. [An update on cholera infection].
    Israil A.
    Bacteriol Virusol Parazitol Epidemiol; 1998 Sep 23; 43(3):185-94. PubMed ID: 9932009
    [No Abstract] [Full Text] [Related]

  • 13. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM, Black RE, Clements ML, Young CR, Lanata C, Sears S, Honda T, Finkelstein R.
    Dev Biol Stand; 1983 Sep 23; 53():59-65. PubMed ID: 6873477
    [Abstract] [Full Text] [Related]

  • 14. When should cholera vaccine be used in cholera-endemic areas?
    Sack DA.
    J Health Popul Nutr; 2003 Dec 23; 21(4):299-303. PubMed ID: 15038584
    [No Abstract] [Full Text] [Related]

  • 15. Cholera: recent updates.
    Weil AA, Ryan ET.
    Curr Opin Infect Dis; 2018 Oct 23; 31(5):455-461. PubMed ID: 30048254
    [Abstract] [Full Text] [Related]

  • 16. Exploiting cholera vaccines as a versatile antigen delivery platform.
    Silva AJ, Eko FO, Benitez JA.
    Biotechnol Lett; 2008 Apr 23; 30(4):571-9. PubMed ID: 18008168
    [Abstract] [Full Text] [Related]

  • 17. Cholera in Africa: new momentum in fighting an old problem.
    Mengel MA.
    Trans R Soc Trop Med Hyg; 2014 Jul 23; 108(7):391-2. PubMed ID: 24836060
    [Abstract] [Full Text] [Related]

  • 18. Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014.
    Azman AS, Rumunu J, Abubakar A, West H, Ciglenecki I, Helderman T, Wamala JF, Vázquez Ode L, Perea W, Sack DA, Legros D, Martin S, Lessler J, Luquero FJ.
    Emerg Infect Dis; 2016 Jun 23; 22(6):1067-70. PubMed ID: 27192187
    [Abstract] [Full Text] [Related]

  • 19. Non-O1 Vibrio cholerae and epidemic cholera.
    Commun Dis Rep CDR Wkly; 1993 Jun 11; 3(24):107. PubMed ID: 7693194
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of cholera.
    Preston NW.
    Lancet; 2004 Mar 13; 363(9412):898. PubMed ID: 15031046
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.